Small hepatocellular carcinomas and thrombocytopenia

Oncology (Switzerland)

Volumn 83, Issue 6, 2012, Pages 331-338

  Carr, Brian I ^a   Guerra, Vito ^b   De Giorgio, Massimo ^c   Fagiuoli, Stefano ^c   Pancoska, Petr ^d  

^a Departments of Nutritional Carcinogenesis   (Italy)

^b NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^c Ospedale Reuniti   (Italy)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Alpha fetoprotein; Hepatocellular carcinoma; Portal vein thrombosis; Thrombocytopenia

Indexed keywords

ALPHA FETOPROTEIN; BILIRUBIN;

AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD ANALYSIS; CANCER SCREENING; DISEASE ASSOCIATION; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RADIOGRAPHY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TUMOR VOLUME;

AGED; ALPHA-FETOPROTEINS; BILIRUBIN; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; HUMANS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; PLATELET COUNT; PORTAL VEIN; THROMBOCYTOPENIA; VENOUS THROMBOSIS;

EID: 84866479435     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000341533     Document Type: Article

References (30)

1. Bosch FX, Ribes J, Diaz M, et al: Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127:S5-S16.
2. Venook AP, Papandreou C, Furuse J, de Guevara LL: The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 2010; 15(suppl 4):5-13.
3. Arii S, Okamoto E, Imamura M: Registries in Japan: current status of hepatocellular carcinoma in Japan. Liver Cancer Study Group of Japan. Semin Surg Oncol 1996; 12: 204-211.
4. Nathan H, Schulick RD, Choti MA, Pawlik TM: Predictors of survival after resection of early hepatocellular carcinoma. Ann Surg 2009; 249: 799-805.
5. Zhou Y, Zhao Y, Li B, Xu D, et al: Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol 2010; 9: 78-84.
6. Rhim H, Lim HK, Choi D: Current status of radiofrequency ablation of hepatocellular carcinoma. World J Gastrointest Surg 2010; 2: 128-136.
7. Tiong L, Maddern GJ: Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2011; 98: 1210-1224.
8. Bruix J, Sherman M: Practice Guidelines Committee, American Association for the Study of Liver Diseases: Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236.
9. Lencioni R, Llovet JM: Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010; 30: 52-60.
10. Carr BI, Pancoska P, Branch RA: HCC in young adults. Hepatogastroenterology 2010; 57: 436-440.
11. Carr BI, Lu SN, Pancoska P: Small hepatocellular carcinoma in Chinese patients. Hepatogastroenterology 2011; 58: 1334-1342.
12. Lu SN, Wang JH, Liu SL, et al: Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma. Cancer 2006; 107: 2212-2222.
13. Wan DW, Tzimas D, Smith JA, et al: Risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States. Am J Gastroenterol 2011; 106: 1994-2000.
14. Azzaroli F, Colecchia A, Lodato F, et al: A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis. Aliment Pharmacol Ther 2006; 24: 129-136.
15. Okuda K, Ohtsuki T, Obata H, et al: Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 1985; 56: 918-928.
16. Grieco A, Pompili M, Caminiti G, et al: Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. Gut 2005; 54: 411-418.
17. Guglielmi A, Ruzzenente A, Pachera S, et al: Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response. Am J Gastroenterol 2008; 103: 597-604.
18. Nomura F, Ohnishi K, Tanabe Y: Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients. Cancer 1989 Oct 15; 64: 1700-1707.
19. Carr BI, Pancoska P, Branch RA: Low alphafetoprotein hepatocellular carcinoma. J Gastroenterol Hepatol 2010; 25: 1543-1549.
20. Carr BI, Buch SC, Kondragunta V, Pancoska P, Branch RA: Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a case cohort study. J Gastroenterol Hepatol 2008; 23: 1259-1266.
21. Pancoska P, Carr BI, Branch RA: Networkbased analysis of survival for unresectable hepatocellular carcinoma. Semin Oncol 2010; 37: 170-181.
22. Hoshida Y, Villanueva A, Kobayashi M, et al: Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 2008; 359: 1995-2004.
23. Pawlik TM, Delman KA, Vauthey JN, et al: Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 2005; 11: 1086-1092.
24. Woo HG, Park ES, Thorgeirsson SS, Kim YJ: Exploring genomic profiles of hepatocellular carcinoma. Mol Carcinog 2011; 50: 235-243.
25. Ramacciato G, Mercantini P, Petrucciani N, et al: Does surgical resection have a role in the treatment of large or multinodular hepatocellular carcinoma? Am Surg 2010; 76: 1189-1197.
26. Hao K, Luk JM, Lee NP, et al: Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters. BMC Cancer 2009; 9: 389.
27. Calvet X, Pons F, Bruix J, et al: Technetium-99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma: relationship between detectability and tumor differentiation. J Nucl Med 1988; 29: 1916-1920.
28. Seo S, Hatano E, Higashi T, Hara T, Tada M, Tamaki N, et al: Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma. Clin Cancer Res 2007; 13: 427-433.
29. Kawamura Y, Arase Y, Ikeda K, et al: Largescale long-term follow-up study of Japanese patients with non-alcoholic fatty liver disease for the onset of hepatocellular carcinoma. Am J Gastroenterol 2012; 107: 253-261.
30. Lu SN, Wang JH, Chen PF, et al: Community-based mass ultrasonographic screening of hepatocellular carcinoma among thrombocytopenic adults. Cancer Epidemiol Biomarkers Prev 2008; 17: 1813-1821.